Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetes
Xelaglifam 是一种新型 GPR40/FFAR1 激动剂，可增强 β-arrestin 募集并持续控制 2 型糖尿病的血糖
期刊:Biomedicine & Pharmacotherapy
影响因子:6.9
doi:10.1016/j.biopha.2024.117044
Jongmin Yoon, Don-Gil Lee, Haengjin Song, Dahae Hong, Ji Soo Park, Changhee Hong, Kyung Mi An, Jung Woo Lee, Joon-Tae Park, Hongchul Yoon, Jihoon Tak, Sang Geon Kim
